Search 

Xuanzhu Biopharmaceutical was founded in 2002. In 2012, it became a wholly-owned subsidiary of Sihuan Pharmaceutical. In 2018, Xuanzhu Biopharmaceutical spun-off and became independent, with a registered capital of RMB1.15 billion. Different from other emerging unprofitable biotechnology companies, Xuanzhu Biopharmaceutical is one of the few domestic innovative drug companies with a complete research and development industry chain. It has not only more than a dozen innovative R&D products, but also support from a leading domestic pharmaceutical company in Sihuan Pharmaceutical. With strong production and commercialization capabilities, Xuanzhu Biopharmaceutical possesses the potential of becoming an international enterprise integrating R&D, manufactuing and marketing platforms.